A competitive inhibitor traps LeuT in an open-to-out conformation.

PubWeight™: 4.86‹?› | Rank: Top 1%

🔗 View Article (PMC 2832577)

Published in Science on December 12, 2008

Authors

Satinder K Singh1, Chayne L Piscitelli, Atsuko Yamashita, Eric Gouaux

Author Affiliations

1: Vollum Institute, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA.

Articles citing this

(truncated to the top 100)

Structure and mechanism of a Na+-independent amino acid transporter. Science (2009) 3.30

X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature (2012) 3.24

Unlocking the molecular secrets of sodium-coupled transporters. Nature (2009) 3.23

X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature (2013) 3.00

Molecular basis of alternating access membrane transport by the sodium-hydantoin transporter Mhp1. Science (2010) 2.52

The rocking bundle: a mechanism for ion-coupled solute flux by symmetrical transporters. Physiology (Bethesda) (2009) 2.41

Single-molecule dynamics of gating in a neurotransmitter transporter homologue. Nature (2010) 2.41

Binding of an octylglucoside detergent molecule in the second substrate (S2) site of LeuT establishes an inhibitor-bound conformation. Proc Natl Acad Sci U S A (2009) 2.25

Alternating access in maltose transporter mediated by rigid-body rotations. Mol Cell (2009) 2.20

Ion/substrate-dependent conformational dynamics of a bacterial homolog of neurotransmitter:sodium symporters. Nat Struct Mol Biol (2010) 2.20

Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue. Nature (2011) 2.18

Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures. Nat Struct Mol Biol (2009) 2.12

Structure and function of Na(+)-symporters with inverted repeats. Curr Opin Struct Biol (2009) 2.10

Mechanism of substrate recognition and transport by an amino acid antiporter. Nature (2010) 1.92

Neurotransmitter/sodium symporter orthologue LeuT has a single high-affinity substrate site. Nature (2010) 1.85

Lipid bilayer regulation of membrane protein function: gramicidin channels as molecular force probes. J R Soc Interface (2009) 1.77

The mechanism of sodium and substrate release from the binding pocket of vSGLT. Nature (2010) 1.74

Structural basis for action by diverse antidepressants on biogenic amine transporters. Nature (2013) 1.56

Structural perspectives on secondary active transporters. Trends Pharmacol Sci (2010) 1.53

Ion-releasing state of a secondary membrane transporter. Biophys J (2009) 1.50

The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter. PLoS One (2011) 1.48

Basis of substrate binding and conservation of selectivity in the CLC family of channels and transporters. Nat Struct Mol Biol (2009) 1.47

Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants. J Biol Chem (2009) 1.46

Binding and orientation of tricyclic antidepressants within the central substrate site of the human serotonin transporter. J Biol Chem (2009) 1.38

Experimental conditions can obscure the second high-affinity site in LeuT. Nat Struct Mol Biol (2012) 1.37

Structures of LeuT in bicelles define conformation and substrate binding in a membrane-like context. Nat Struct Mol Biol (2012) 1.37

The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango. J Neurochem (2009) 1.36

Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter. J Biol Chem (2009) 1.33

Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. J Med Chem (2011) 1.30

Ion-controlled conformational dynamics in the outward-open transition from an occluded state of LeuT. Biophys J (2012) 1.30

Crystal structure of the carnitine transporter and insights into the antiport mechanism. Nat Struct Mol Biol (2010) 1.30

Neurotransmitter and psychostimulant recognition by the dopamine transporter. Nature (2015) 1.30

Comparison of human solute carriers. Protein Sci (2010) 1.29

Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET. Proc Natl Acad Sci U S A (2011) 1.29

Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding. J Biol Chem (2010) 1.27

A mechanism for intracellular release of Na+ by neurotransmitter/sodium symporters. Nat Struct Mol Biol (2014) 1.26

Fluoxetine (Prozac) binding to serotonin transporter is modulated by chloride and conformational changes. J Neurosci (2009) 1.23

X-ray structures and mechanism of the human serotonin transporter. Nature (2016) 1.21

The Na+/I- symporter (NIS): mechanism and medical impact. Endocr Rev (2013) 1.21

The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter. Mol Pharmacol (2010) 1.21

Modeling and dynamics of the inward-facing state of a Na+/Cl- dependent neurotransmitter transporter homologue. PLoS Comput Biol (2010) 1.20

Conformational dynamics of ligand-dependent alternating access in LeuT. Nat Struct Mol Biol (2014) 1.19

The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters. J Biol Chem (2012) 1.19

SLC6 transporters: structure, function, regulation, disease association and therapeutics. Mol Aspects Med (2013) 1.18

Mutational analysis of the high-affinity zinc binding site validates a refined human dopamine transporter homology model. PLoS Comput Biol (2013) 1.14

Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates. J Pharmacol Exp Ther (2013) 1.12

The binding sites for benztropines and dopamine in the dopamine transporter overlap. Neuropharmacology (2010) 1.11

Bivalent phenethylamines as novel dopamine transporter inhibitors: evidence for multiple substrate-binding sites in a single transporter. J Neurochem (2010) 1.10

Chloride binding site of neurotransmitter sodium symporters. Proc Natl Acad Sci U S A (2013) 1.09

Novel molecular targets of dezocine and their clinical implications. Anesthesiology (2014) 1.08

The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors. PLoS One (2011) 1.07

NMR characterization of membrane protein-detergent micelle solutions by use of microcoil equipment. J Am Chem Soc (2009) 1.07

Coupled global and local changes direct substrate translocation by neurotransmitter-sodium symporter ortholog LeuT. Biophys J (2013) 1.07

How LeuT shapes our understanding of the mechanisms of sodium-coupled neurotransmitter transporters. J Physiol (2013) 1.06

Substrate binds in the S1 site of the F253A mutant of LeuT, a neurotransmitter sodium symporter homologue. EMBO Rep (2012) 1.05

Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters. Proc Natl Acad Sci U S A (2011) 1.04

The sodium/galactose symporter crystal structure is a dynamic, not so occluded state. Mol Biosyst (2010) 1.01

Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter. Drug Alcohol Depend (2014) 1.01

Substrate and drug binding sites in LeuT. Curr Opin Struct Biol (2010) 1.01

Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket. J Biol Chem (2012) 1.01

Insights into transport mechanism from LeuT engineered to transport tryptophan. EMBO J (2011) 1.00

Unbiased simulations reveal the inward-facing conformation of the human serotonin transporter and Na(+) ion release. PLoS Comput Biol (2011) 1.00

Mechanism of anion selectivity and stoichiometry of the Na+/I- symporter (NIS). Proc Natl Acad Sci U S A (2011) 0.99

Structural insights into the activation mechanism of melibiose permease by sodium binding. Proc Natl Acad Sci U S A (2010) 0.99

Topologically conserved residues direct heme transport in HRG-1-related proteins. J Biol Chem (2011) 0.98

Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine. J Biol Chem (2010) 0.97

Ligand effects on cross-linking support a conformational mechanism for serotonin transport. J Biol Chem (2009) 0.96

Visualizing functional motions of membrane transporters with molecular dynamics simulations. Biochemistry (2013) 0.96

The cost of living in the membrane: a case study of hydrophobic mismatch for the multi-segment protein LeuT. Chem Phys Lipids (2013) 0.96

The membrane protein LeuT in micellar systems: aggregation dynamics and detergent binding to the S2 site. J Am Chem Soc (2013) 0.95

Molecular modeling and ligand docking for solute carrier (SLC) transporters. Curr Top Med Chem (2013) 0.95

Complete mapping of substrate translocation highlights the role of LeuT N-terminal segment in regulating transport cycle. PLoS Comput Biol (2014) 0.94

Probing binding pocket of serotonin transporter by single molecular force spectroscopy on living cells. J Biol Chem (2011) 0.94

High selectivity of the γ-aminobutyric acid transporter 2 (GAT-2, SLC6A13) revealed by structure-based approach. J Biol Chem (2012) 0.94

Reconstructing a chloride-binding site in a bacterial neurotransmitter transporter homologue. J Biol Chem (2010) 0.93

Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease. J Biol Chem (2012) 0.93

Comparative modeling of the human monoamine transporters: similarities in substrate binding. ACS Chem Neurosci (2012) 0.92

Cytoplasmic permeation pathway of neurotransmitter transporters. Biochemistry (2011) 0.92

The mechanism of substrate release by the aspartate transporter GltPh: insights from simulations. Mol Biosyst (2010) 0.92

Spontaneous Inward Opening of the Dopamine Transporter Is Triggered by PIP2-Regulated Dynamics of the N-Terminus. ACS Chem Neurosci (2015) 0.91

NbIT--a new information theory-based analysis of allosteric mechanisms reveals residues that underlie function in the leucine transporter LeuT. PLoS Comput Biol (2014) 0.91

A gate-free pathway for substrate release from the inward-facing state of the Na⁺-galactose transporter. Biochim Biophys Acta (2011) 0.91

LeuT conformational sampling utilizing accelerated molecular dynamics and principal component analysis. Biophys J (2012) 0.90

Transport activity-dependent intracellular sorting of the yeast general amino acid permease. Mol Biol Cell (2011) 0.90

Transmembrane topology of the mammalian Slc11a2 iron transporter. Biochemistry (2009) 0.89

Understanding transporter specificity and the discrete appearance of channel-like gating domains in transporters. Front Pharmacol (2014) 0.89

Monoamine transporter structure, function, dynamics, and drug discovery: a computational perspective. AAPS J (2012) 0.89

Loop diuretic and ion-binding residues revealed by scanning mutagenesis of transmembrane helix 3 (TM3) of Na-K-Cl cotransporter (NKCC1). J Biol Chem (2012) 0.88

Microseconds simulations reveal a new sodium-binding site and the mechanism of sodium-coupled substrate uptake by LeuT. J Biol Chem (2014) 0.88

The two Na+ sites in the human serotonin transporter play distinct roles in the ion coupling and electrogenicity of transport. J Biol Chem (2013) 0.88

Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transporters. J Med Chem (2010) 0.87

Biochemistry. An almost-complete movie. Science (2008) 0.87

Ligand induced conformational changes of the human serotonin transporter revealed by molecular dynamics simulations. PLoS One (2013) 0.87

Mechanism of the Association between Na+ Binding and Conformations at the Intracellular Gate in Neurotransmitter:Sodium Symporters. J Biol Chem (2015) 0.87

Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site. J Biol Chem (2014) 0.87

Insights into the Modulation of Dopamine Transporter Function by Amphetamine, Orphenadrine, and Cocaine Binding. Front Neurol (2015) 0.86

Identification of novel serotonin transporter compounds by virtual screening. J Chem Inf Model (2014) 0.86

To be, or not to be two sites: that is the question about LeuT substrate binding. J Gen Physiol (2011) 0.86

Substrate-induced Unlocking of the Inner Gate Determines the Catalytic Efficiency of a Neurotransmitter:Sodium Symporter. J Biol Chem (2015) 0.86

Specific analogues uncouple transport, signalling, oligo-ubiquitination and endocytosis in the yeast Gap1 amino acid transceptor. Mol Microbiol (2014) 0.84

Articles cited by this

Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters. Nature (2005) 12.56

The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na+/sugar symport. Science (2008) 4.94

Flux coupling in a neuronal glutamate transporter. Nature (1996) 4.43

Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature (2007) 4.29

The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site. Mol Cell (2008) 4.29

LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science (2007) 4.08

The packing density in proteins: standard radii and volumes. J Mol Biol (1999) 3.48

Mechanism for alternating access in neurotransmitter transporters. Proc Natl Acad Sci U S A (2008) 3.24

A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function. Mol Pharmacol (2006) 3.23

Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med (2000) 2.53

Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflugers Arch (2003) 2.45

Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet (2005) 2.44

Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend (1998) 2.28

Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry (2003) 2.12

Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants. J Biol Chem (2005) 2.03

Neurotransmitter transporters in the central nervous system. Pharmacol Rev (1999) 1.98

X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet (2001) 1.95

Substrate binding and formation of an occluded state in the leucine transporter. Biophys J (2007) 1.77

Neuronal and glial glycine transporters have different stoichiometries. Neuron (2000) 1.72

Characterization of a functional bacterial homologue of sodium-dependent neurotransmitter transporters. J Biol Chem (2003) 1.70

Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenomics J (2002) 1.60

Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I. J Biol Chem (2003) 1.60

Transport mechanisms in acetylcholine and monoamine storage. FASEB J (2000) 1.49

Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport. J Biol Chem (1979) 1.32

Common mechanisms of inhibition for the Na+/glucose (hSGLT1) and Na+/Cl-/GABA (hGAT1) cotransporters. Br J Pharmacol (2001) 1.26

Role of the GABA transporter in epilepsy. Adv Exp Med Biol (2004) 1.26

Structure and function of sodium-coupled GABA and glutamate transporters. J Membr Biol (2007) 1.23

GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects. Curr Pharm Des (2000) 1.21

Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J (2001) 1.21

The substrates of the gamma-aminobutyric acid transporter GAT-1 induce structural rearrangements around the interface of transmembrane domains 1 and 6. J Biol Chem (2008) 1.19

Antidepressants targeting the serotonin reuptake transporter act via a competitive mechanism. J Pharmacol Exp Ther (2008) 1.14

The aqueous accessibility in the external half of transmembrane domain I of the GABA transporter GAT-1 Is modulated by its ligands. J Biol Chem (2004) 1.11

The osmolyte strategy of normal human keratinocytes in maintaining cell homeostasis. J Invest Dermatol (2004) 1.00

High-affinity uptake of [3H]norepinephrine by primary astrocyte cultures and its inhibition by tricyclic antidepressants. J Neurochem (1983) 0.92

Articles by these authors

Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters. Nature (2005) 12.56

Structure of acid-sensing ion channel 1 at 1.9 A resolution and low pH. Nature (2007) 8.04

X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature (2009) 6.81

Structure of a glutamate transporter homologue from Pyrococcus horikoshii. Nature (2004) 6.02

Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature (2011) 5.93

Mechanism of glutamate receptor desensitization. Nature (2002) 5.36

Subunit arrangement and function in NMDA receptors. Nature (2005) 5.21

Structural basis for modulation and agonist specificity of HCN pacemaker channels. Nature (2003) 4.80

Fluorescence-detection size-exclusion chromatography for precrystallization screening of integral membrane proteins. Structure (2006) 4.79

Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature (2003) 4.71

Structural basis for partial agonist action at ionotropic glutamate receptors. Nat Neurosci (2003) 4.55

Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature (2007) 4.29

Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature (2009) 4.18

Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter. Nature (2007) 4.14

Pore architecture and ion sites in acid-sensing ion channels and P2X receptors. Nature (2009) 3.37

Structure and mechanism of a Na+-independent amino acid transporter. Science (2009) 3.30

X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature (2012) 3.24

Unlocking the molecular secrets of sodium-coupled transporters. Nature (2009) 3.23

Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core. EMBO J (2003) 3.15

X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature (2013) 3.00

Dynamic superresolution imaging of endogenous proteins on living cells at ultra-high density. Biophys J (2010) 2.65

Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor. Cell (2006) 2.63

Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature (2012) 2.53

Crystal structure and association behaviour of the GluR2 amino-terminal domain. EMBO J (2009) 2.19

Mechanism of partial agonist action at the NR1 subunit of NMDA receptors. Neuron (2005) 2.07

How capping protein binds the barbed end of the actin filament. Curr Biol (2003) 2.05

Mechanism of positive allosteric modulators acting on AMPA receptors. J Neurosci (2005) 1.97

Neurotransmitter/sodium symporter orthologue LeuT has a single high-affinity substrate site. Nature (2010) 1.85

Structural plasticity and dynamic selectivity of acid-sensing ion channel-spider toxin complexes. Nature (2012) 1.84

Tuning activation of the AMPA-sensitive GluR2 ion channel by genetic adjustment of agonist-induced conformational changes. Proc Natl Acad Sci U S A (2003) 1.81

FISH analysis of 142 EGFP transgene integration sites into the mouse genome. Genomics (2002) 1.66

Capping protein binding to actin in yeast: biochemical mechanism and physiological relevance. J Cell Biol (2004) 1.62

Structural basis for action by diverse antidepressants on biogenic amine transporters. Nature (2013) 1.56

Trimeric subunit stoichiometry of the glutamate transporters from Bacillus caldotenax and Bacillus stearothermophilus. Biochemistry (2003) 1.50

Mechanism of activation and selectivity in a ligand-gated ion channel: structural and functional studies of GluR2 and quisqualate. Biochemistry (2002) 1.45

Crystal structure of the Vibrio cholerae cytolysin (VCC) pro-toxin and its assembly into a heptameric transmembrane pore. J Mol Biol (2005) 1.42

Structural basis of actin filament capping at the barbed-end: a cryo-electron microscopy study. EMBO J (2006) 1.41

Molecular bases of cyclodextrin adapter interactions with engineered protein nanopores. Proc Natl Acad Sci U S A (2010) 1.41

A fluorescence-detection size-exclusion chromatography-based thermostability assay for membrane protein precrystallization screening. Structure (2012) 1.38

Structures of LeuT in bicelles define conformation and substrate binding in a membrane-like context. Nat Struct Mol Biol (2012) 1.37

Crystal structure of the C-terminal half of tropomodulin and structural basis of actin filament pointed-end capping. Biophys J (2002) 1.35

Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart. J Biol Chem (2001) 1.33

Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal. Biochemistry (2003) 1.27

Beta-barrel membrane protein folding and structure viewed through the lens of alpha-hemolysin. Biochim Biophys Acta (2003) 1.20

Amino terminal domains of the NMDA receptor are organized as local heterodimers. PLoS One (2011) 1.18

Arresting and releasing Staphylococcal alpha-hemolysin at intermediate stages of pore formation by engineered disulfide bonds. Protein Sci (2003) 1.18

High resolution crystallographic studies of alpha-hemolysin-phospholipid complexes define heptamer-lipid head group interactions: implication for understanding protein-lipid interactions. Protein Sci (2004) 1.15

Competitive antagonism of AMPA receptors by ligands of different classes: crystal structure of ATPO bound to the GluR2 ligand-binding core, in comparison with DNQX. J Med Chem (2003) 1.10

The New York Consortium on Membrane Protein Structure (NYCOMPS): a high-throughput platform for structural genomics of integral membrane proteins. J Struct Funct Genomics (2010) 1.07

How LeuT shapes our understanding of the mechanisms of sodium-coupled neurotransmitter transporters. J Physiol (2013) 1.06

Substrate binds in the S1 site of the F253A mutant of LeuT, a neurotransmitter sodium symporter homologue. EMBO Rep (2012) 1.05

A vibrational spectroscopic investigation of interactions of agonists with GluR0, a prokaryotic glutamate receptor. Biochemistry (2002) 1.01

Insights into transport mechanism from LeuT engineered to transport tryptophan. EMBO J (2011) 1.00

Three-dimensional structure of the ligand-binding core of GluR2 in complex with the agonist (S)-ATPA: implications for receptor subunit selectivity. J Med Chem (2003) 0.95

Vibrio cholerae cytolysin is composed of an alpha-hemolysin-like core. Protein Sci (2003) 0.90

Crystal structures of Lymnaea stagnalis AChBP in complex with neonicotinoid insecticides imidacloprid and clothianidin. Invert Neurosci (2008) 0.90

Unanticipated parallels in architecture and mechanism between ATP-gated P2X receptors and acid sensing ion channels. Curr Opin Struct Biol (2013) 0.89

Architecture of fully occupied GluA2 AMPA receptor-TARP complex elucidated by cryo-EM. Nature (2016) 0.87

Met/HGF receptor activation is regulated by juxtamembrane Ser985 phosphorylation in hepatocytes. Cytokine (2013) 0.81

Pharmacokinetics and pharmacodynamics following intravenous administration of recombinant human hepatocyte growth factor in rats with renal injury. Pharmacology (2014) 0.80

Molecular bases of multimodal regulation of a fungal transient receptor potential (TRP) channel. J Biol Chem (2013) 0.80

GFP-based evaluation system of recombinant expression through the secretory pathway in insect cells and its application to the extracellular domains of class C GPCRs. Protein Sci (2011) 0.79

High-resolution Native-PAGE for membrane proteins capable of fluorescence detection and hydrodynamic state evaluation. Anal Biochem (2011) 0.79

Structure-based functional design of chemical ligands for AMPA-subtype glutamate receptors. J Mol Neurosci (2002) 0.78

Novel dicarboxylate selectivity in an insect glutamate transporter homolog. PLoS One (2013) 0.77

General flexible nature of the cytosolic regions of fungal transient receptor potential (TRP) channels, revealed by expression screening using GFP-fusion techniques. Protein Sci (2014) 0.75

Aromatase-null mice expressing enhanced green fluorescent protein in germ cells provide a model system to assess estrogen-dependent ovulatory responses. Transgenic Res (2013) 0.75

Structure of β-adrenergic receptors. Methods Enzymol (2013) 0.75

Isolation of a novel mouse variant of the drs tumor suppressor gene. Cancer Lett (2002) 0.75

[Structural basis of multimodal responses by TRP channels]. Seikagaku (2014) 0.75

[Development of innovative methods to support crystallization of eukaryotic membrane proteins: crystallizability-based target selection using GFP fusion technique and folding-controlled protein expression in methylotrophic yeast]. Tanpakushitsu Kakusan Koso (2009) 0.75